EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS

被引：0
|
作者：
ROTE, WE [1 ]
DEMPSEY, EM [1 ]
OLDESCHULTE, GL [1 ]
ARDECKY, RJ [1 ]
TAMURA, SY [1 ]
NUTT, RF [1 ]
BERGUM, PW [1 ]
TRAN, HS [1 ]
ANDERSON, SM [1 ]
VLASUK, GP [1 ]
机构：
[1] CORVAS INT INC,SAN DIEGO,CA
来源：
CIRCULATION | 1994年 / 90卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：344 / 344
页数：1
相关论文
共 50 条
  • [21] The antithrombotic efficacy of AT-14595 a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis
    Cho, JH
    Yun, CH
    Seo, HS
    Koga, T
    Dan, T
    Koo, BA
    Kim, HY
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (06) : 1512 - 1520
  • [22] Suppression of collagen-induced arthritis and cytokine production by a novel orally-active cytokine inhibitor
    Morand, Eric
    Hall, P.
    Tapley, P.
    Gilbert, T.
    Danylec, B.
    Iskander, M.
    INFLAMMATION RESEARCH, 2007, 56 : S401 - S402
  • [23] AN ORALLY-ACTIVE, SPECIFIC INHIBITOR OF FACTOR XA DOES NOT FACILITATE HEMORRHAGE AT THE EFFECTIVE DOSES IN RAT THROMBOSIS MODEL
    TANABE, K
    HONDA, Y
    KUNITADA, S
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1312 - 1312
  • [24] Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism
    Ochi, Yasuo
    Yamada, Hiroyuki
    Mori, Hiroshi
    Nakanishi, Yasutomo
    Nishikawa, Satoshi
    Kayasuga, Ryoji
    Kawada, Naoki
    Kunishige, Akiko
    Hashimoto, Yasuaki
    Tanaka, Makoto
    Sugitani, Masafumi
    Kawabata, Kazuhito
    BONE, 2011, 49 (06) : 1351 - 1356
  • [25] SC-54684A - AN ORALLY-ACTIVE INHIBITOR OF PLATELET-AGGREGATION
    NICHOLSON, NS
    PANZERKNODLE, SG
    SALYERS, AK
    TAITE, BB
    SZALONY, JA
    HAAS, NF
    KING, LW
    ZABLOCKI, JA
    KELLER, BT
    BROSCHAT, K
    ENGLEMAN, VW
    HERIN, M
    JACQMIN, P
    FEIGEN, LP
    CIRCULATION, 1995, 91 (02) : 403 - 410
  • [26] Comparative evaluation of new orally active thioglycosides on various thrombosis models
    Csomor, K
    Kárpáti, E
    Komlódi, Z
    Szabó, G
    Kuszmann, J
    THROMBOSIS AND HAEMOSTASIS, 1999, : 674 - 674
  • [27] AN ORALLY-ACTIVE, SPECIFIC INHIBITOR OF FACTOR-XA PREVENTS THROMBOSIS WITHOUT AFFECTING BLEEDING-TIME IN RATS
    TANABE, K
    HARA, T
    MORISHIMA, Y
    ISHIHARA, H
    YOKOYAMA, A
    HONDA, Y
    IWAMOTO, M
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 890 - 890
  • [28] EFFECT OF A NOVEL THROMBIN ACTIVE-SITE INHIBITOR ON ARTERIAL AND VENOUS THROMBOSIS
    SCHUMACHER, WA
    BALASUBRAMANIAN, N
    STLAURENT, DR
    SEILER, SM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 259 (02) : 165 - 171
  • [29] COMPARATIVE-STUDY ON THE ANTI-THROMBOTIC EFFECTS OF A SYNTHETIC THROMBIN INHIBITOR AND OF HEPARIN IN ANIMAL-MODELS
    HAUPTMANN, J
    BARTH, A
    SCHONBERGER, FP
    MARKWARDT, F
    BIOMEDICA BIOCHIMICA ACTA, 1983, 42 (7-8) : 959 - 965
  • [30] ANIMAL-MODELS FOR EVALUATION OF ARTHRITIS DRUGS
    GREENWALD, RA
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1991, 13 (02): : 75 - 83
12345